Agilent Technologies (FRA:AG8) Tax Expense: €142 Mil (TTM As of Apr. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:AG8 Agilent Technologies Inc FRA:AG8
93 GF Score
Price €117.10
GF Value €127.43
Valuation Fairly Valued
! 1 Warning Sign
View Full Analysis

What is Agilent Technologies Tax Expense?

Agilent Technologies FRA:AG8 -0.47% 93 Tax Expense is €142 Mil as of Apr. 2026. GuruFocus rates FRA:AG8 with a GF Score™ of 93/100 and a GF Value™ of €127.43 (Fairly Valued). The stock has 1 warning sign investors should review.

Agilent Technologies's tax expense for the months ended in Apr. 2026 was €59 Mil. Its tax expense for the trailing twelve months (TTM) ended in Apr. 2026 was €142 Mil.


Agilent Technologies  (FRA:AG8) Tax Expense Explanation

In the long run, income before tax and taxable income will likely be more similar than they are in any given period. If the one is less in earlier years, then it will be greater in later years. Deferred taxes will reverse themselves in the long run and in total will zero out, unless there is something like a change in tax rates in the intervening period. A deferred tax payable results from a tax break in the early years and will reverse itself in later years; a deferred tax receivable results from more taxes being paid in early years than the tax expense reported to shareholders and will again reverse itself in later years. The deferred tax amount is computed by estimating the amount and the timing of the reversal and multiplying that by the appropriate tax rates.


Agilent Technologies Tax Expense Related Terms


Agilent Technologies Tax Expense Historical Data

* Premium members only.

The historical data trend for Agilent Technologies's Tax Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Agilent Technologies Tax Expense Chart

Agilent Technologies Annual Data
Trend Oct16 Oct17 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23 Oct24 Oct25
Tax Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 129.30 253.75 93.75 212.98 113.39

Agilent Technologies Quarterly Data
Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26
Tax Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 40.05 25.71 6.87 50.21 59.00
FRA:AG8
93GF Score
Agilent Technologies Inc FRA:AG8
Tax Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Agilent Technologies Tax Expense Calculation

Tax paid by the company. It is computed in by multiplying the income before tax number, as reported to shareholders, by the appropriate tax rate. In reality, the computation is typically considerably more complex due to things such as expenses considered not deductible by taxing authorities ("add backs"), the range of tax rates applicable to various levels of income, different tax rates in different jurisdictions, multiple layers of tax on income, and other issues.

Tax Expense for the trailing twelve months (TTM) ended in Apr. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €142 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Tax Expense →
What does a Tax Expense of €142 Mil mean?
Agilent Technologies (FRA:AG8) has a Tax Expense of €142 Mil as of Apr. 2026. Tax expense is the amount of tax the company pays in an accounting period. View historical data on Agilent Technologies and its competitors.
Is Agilent Technologies' Tax Expense too high?
Agilent Technologies' current Tax Expense is €142 Mil. Overall, Agilent Technologies has a GF Score™ of 93/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Agilent Technologies' Tax Expense compare to NTRA and WAT?
Agilent Technologies' Tax Expense of €142 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tax Expense for a Medical Diagnostics & Research company?
A good Tax Expense depends on the Medical Diagnostics & Research industry context. However, Tax Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tax Expense mean?
A high Tax Expense can signal that a stock is expensive relative to its fundamentals. Tax expense is the amount of tax the company pays in an accounting period. View historical data on Agilent Technologies and its competitors. Agilent Technologies's current Tax Expense is €142 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Agilent Technologies stock overvalued right now?
Based on GuruFocus' analysis, Agilent Technologies (FRA:AG8) is currently considered Fairly Valued. The stock's GF Value™ is €127.43, compared to a current price of €117.10 — trading 8.1% below its estimated fair value. The current Tax Expense is €142 Mil. Agilent Technologies' overall GF Score™ is 93/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tax Expense calculated?
Tax Expense is calculated from a company's financial statements. For Agilent Technologies (FRA:AG8), the current Tax Expense is €142 Mil as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Agilent Technologies (FRA:AG8) Overvalued in 2026?

Based on GuruFocus' analysis, Agilent Technologies stock appears to be undervalued. The current stock price of €117.10 is trading 8.1% below its estimated GF Value™ of €127.43. GuruFocus considers Agilent Technologies to be Fairly Valued.

Key valuation signals for FRA:AG8:

  • Tax Expense: €142 Mil
  • GF Value™: €127.43 vs. price of €117.10 (8.1% below fair value)
  • GF Score™: 93/100 with 1 warning sign

No single metric tells the full story. See the FRA:AG8 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Agilent Technologies Business Description

Address 5301 Stevens Creek Boulevard, Santa Clara, CA, USA, 95051
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life science and diagnostic firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and diagnostics, cross lab operations consisting of consumables and services, and applied end markets. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, which we view as the stickiest end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the US and China representing the largest country concentrations.
93GF Score

Get the complete analysis for FRA:AG8

Tax Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€117.10
Price
€127.43
GF Value